MedPath

Quality Control of CE-Certified Phonak Hearing Aids - 2019_23

Not Applicable
Withdrawn
Conditions
Hearing Loss
Interventions
Device: Phone Application
Registration Number
NCT04048187
Lead Sponsor
Sonova AG
Brief Summary

Phonak Hearing Devices pass through different development and study phases. At an early stage, feasibiltiy studies are conducted to investigate new algorithms, features and functions in an isolated manner. If the benefit is proven, their performance is then investigated regarding interpendency between all available algorithms, features and functions running in parallel in a hearing aid (pivotal/pre-validation studies) and, resulting from the pre-validation studies, they get optimized. Prior to product launch, the Phonak Hearing Systems get reviewed by a final quality control in terms of clinical trials. This is a pre-validation study, investigating improved algorithms, features, functions and wearing comfort. This will be a clinical investigation which will be conducted mono centric at Sonova AG Headquarters based in Stäfa (Switzerland).

Detailed Description

This study will prove the overall performance and system context of the functionality in the mobile application in combination with hearing devices under real life conditions with experienced hearing aid users. The enduser should be able to adjust their hearing aid settings by App.

The app allows the user to change e.g. the loudness of the hearing aids and to create hearing scenarios by themselves. The users also shall be able to accept a conferecene call, which they will receive from the investigator via App.

This will be a clinical investigation which will be conducted mono centric at Sonova AG Headquarters based in Stäfa (Switzerland).

Recruitment & Eligibility

Status
WITHDRAWN
Sex
All
Target Recruitment
Not specified
Inclusion Criteria
  • experienced hearing aid users (minimum age: 18 years, moderate to moderate/severe hearing loss)
  • modern subjects with an affinity to new technology
  • willingness and interest in testing Apps
  • owning a compatible smartphone
  • Healthy outer ear
  • willingness to wear behind the ear hearing aids
  • Informed Consent as documented by signature
Exclusion Criteria
  • the audiogramm is not in the fitting range of the intended hearing aid
  • limited mobility and not in the position to attend weekly appointments in Stäfa (Switzerland)
  • participant is not able to describe experiences and hearing impressions

Study & Design

Study Type
INTERVENTIONAL
Study Design
SINGLE_GROUP
Arm && Interventions
GroupInterventionDescription
Phone ApplicationPhone Application-
Primary Outcome Measures
NameTimeMethod
Successful creation of a Custom Sceario (%)4 weeks

Endusers of the phoneApp are able to add a custum scenario to the app.

Successful answering of conference call (%)2 weeks

Endusers of the phoneApp are able to answering the conference call?

Secondary Outcome Measures
NameTimeMethod

Trial Locations

Locations (1)

Sonova AG

🇨🇭

Stäfa, Switzerland

© Copyright 2025. All Rights Reserved by MedPath